AI assistant
Sending…
Celularity Inc — Director's Dealing 2022
Oct 4, 2022
34506_dirs_2022-10-04_80d35be1-c895-485d-8ee5-a4004f9e5579.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2022-10-03
Reporting Person: Kilcoyne Adrian (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-10-03 | Stock Option (Right to Buy) | $2.19 | A | 66226 | Acquired | 2032-10-03 | Class A Common Stock (66226) | Direct |
Footnotes
F1: This option was granted under the Issuer's 2021 Equity Incentive Plan. The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.
More from Celularity Inc
Regulatory Filings
2026
May 28
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15